AI joins forces with radiologists in massive liver tumor diagnosis trial
NCT ID NCT07153783
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 25 times
Summary
This completed study tested whether an artificial intelligence (AI) system can help doctors accurately diagnose different types of liver tumors using contrast-enhanced CT scans. Over 10,000 adults participated. The goal was to see if AI can improve real-world diagnosis and patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110004, China
Conditions
Explore the condition pages connected to this study.